Product Information

NORVASC 10 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $11.9758 per EA under NDC 58151035588. Its NADAC has been published 125 times since Apr 3, 2024.

FDA first approved this application on Jul 31, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the amlodipine besylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

NORVASC 10 MG TABLET

amlodipine besylate
$11.9758per EA
High Outlier

Strength

10 mg/1

NDC

58151035588

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

AMLODIPINE BESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA019787

FDA Approved

7/31/1992

TE Code

AB

On Market Since

2/9/2024

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for NORVASC 10 MG TABLET has been published 125 times since Apr 3, 2024, and over the history we have for it it has risen 7.0%. The table below summarizes its recorded NADAC range and movement.

Current price$11.9758 per EA
All-time high$11.9940 (Jul 15, 2026)
All-time low$11.1170 (Dec 18, 2024)
52-week high$11.9940
52-week low$11.2785
Median price$11.2964
Average price$11.4186
Largest weekly change+5.0% (Jan 7, 2026)
Weeks tracked125
Tracking sinceApr 3, 2024

Price History

1W

0.0%

1M

-0.2%

3M

-0.2%

6M

+1.0%

1Y

+5.9%

3Y

N/A

5Y

N/A

All

+7.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NORVASC 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NORVASC 10 MG TABLET, manufactured by Viatris Specialty LLC, is $11.9758 per EA (NDC 58151035588), effective Aug 19, 2026.

How has the price of NORVASC 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for NORVASC 10 MG TABLET has risen 7.0%. It has been tracked across 125 weekly CMS publications since Apr 3, 2024.

What are the highest and lowest recorded NADAC prices for NORVASC 10 MG TABLET?

Since Apr 3, 2024, the NADAC for NORVASC 10 MG TABLET has ranged from a low of $11.1170 (Dec 18, 2024) to a high of $11.9940 (Jul 15, 2026), with a median of $11.2964 per EA.

Are there cheaper alternatives to NORVASC 10 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 10 MG TAB, is $0.0150 per EA — about 99% below NORVASC 10 MG TABLET.

Who manufactures NORVASC 10 MG TABLET?

NORVASC 10 MG TABLET (NDC 58151035588) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.